Key result
Artificial neural network outperforms Framingham risk score in predicting coronary heart disease.
Why the study?
Classic risk factors do not entirely predict coronary heart disease risk, and innovative methods may improve prediction beyond the Framingham risk score.
Does an artificial neural network model improve the prediction of coronary heart disease risk compared to the Framingham risk score in subjects from the FHS offspring cohort?
Observational (n=3,066)
Does an artificial neural network model improve the prediction of coronary heart disease risk compared to the Framingham risk score in subjects from the FHS offspring cohort?
An artificial neural network model may provide better precision-recall and identification of high-risk subjects for coronary heart disease compared to the traditional Framingham risk score.
ANN may aid high-risk CHD identification in similar cohorts; leaves open prospective validation and outcome impact.
BACKGROUND AND OBJECTIVES: Cardiovascular diseases, such as coronary heart disease (CHD), are the main cause of mortality and morbidity worldwide. Although CHD cannot be entirely predicted by classic risk factors, it is preventable. Therefore, predicting CHD risk is crucial to clinical cardiology research, and the development of innovative methods for predicting CHD risk is of great practical interest. The Framingham risk score (FRS) is one of the most frequently implemented risk models. However, recent advances in the field of analytics may enhance the prediction of CHD risk beyond the FRS. Here, we propose a model based on an artificial neural network (ANN) for predicting CHD risk with respect to the Framingham Heart Study (FHS) dataset. The performance of this model was compared to that of the FRS. METHODS: A sample of 3066 subjects from the FHS offspring cohort was subjected to an ANN. A multilayer perceptron ANN architecture was used and the lift, gains, receiver operating characteristic (ROC), and precision-recall predicted by the ANN were compared with those of the FRS. RESULTS: The lift and gain curves of the ANN model outperformed those of the FRS model in terms of top percentiles. The ROC curve showed that, for higher risk scores, the ANN model had higher sensitivity and higher specificity than those of the FRS model, although its area under the curve (AUC) was lower. For the precision-recall measures, the ANN generated significantly better results than the FRS with a higher AUC. CONCLUSIONS: The findings suggest that the ANN model is a promising approach for predicting CHD risk and a good screening procedure to identify high-risk subjects.
No takes yet. Share an insight, caveat, or question.
Goldman et al. (2021) conducted an observational in Coronary heart disease risk (n=3,066). Artificial neural network (ANN) model vs. Framingham risk score (FRS) was evaluated on Prediction of CHD risk (lift, gains, ROC, precision-recall). An artificial neural network model outperformed the Framingham risk score in predicting coronary heart disease risk, demonstrating higher sensitivity, specificity, and precision-recall AUC.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: